Clinical
Research
Publications
News
About us
Contact
Home

Revolutionize Precision Medicine

We unravel disease mechanisms
by identifying aberrant activities
of cell signaling pathways

news

InnoSIGN Launches New Suite Products for Pharmaceutical Research and Clinical Studies

Read article All news
news

InnoSIGN appoints Eric Lindquist new Chief Executive Officer

Read article All news
events

Identifying mutation-independent signaling pathway activation in molecular subtypes of triple negative breast cancers

Read article All events
events

Racial differences in estrogen receptor signaling pathway activity in breast cancer patients

Read article All events

Cookies

We use cookies and other technologies to personalize content, as well as to provide social media features on this Website in accordance with our Cookie Policy. By clicking “Accept” you are directing InnoSIGN to disclose your personal information to third parties for the purposes stated above.

Accept all Only functional